StudyFinder

A Natural History Study of the Gangliosidoses

Status: Recruiting

This study's primary aims are to define and characterize disease progression for the infantile and juvenile forms of the gangliosidoses, and the late-onset forms of gangliosidosis, including their heterogeneity; and to observe treatment outcomes for any treatments tried. The secondary aims of this study are to understand the neurological involvement in late-onset gangliosidosis; and to collect data on disease progression that can be used for creation of an objective disease stage and severity index.

I'm interested

Age: Not specified
Healthy Volunteers:
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• documented gangliosidosis disease
• able to complete neuropsychological and neurobehavioral assessments
• Late-onset gangliosidosis subjects must be able to tolerate MRI of the head
Exclusion Criteria:

• none
Conditions:

Rare Diseases

Keywords:

GM1 Gangliosidosis, GM2 Gangliosidosis, Sandhoff Disease, Tay-Sachs Disease

Contact(s): Jeanine Jarnes - utzx0002@umn.edu
Principal Investigator: Jeanine Jarnes
IRB Number: 1007M85712
System ID: 20889
See this study on ClinicalTrials.gov

Back